Givaudan to acquire Alderys
Strengthens Givaudan’s expertise in sustainable disruptive biotechnology process.
As part of its long-term strategy to expand its capabilities in bioengineering technologies, Givaudan has announced that it is to acquire Alderys.
Founded in 2009, Alderys is a French biotechnology company headquartered in Orsay, France. The company develops innovative approaches to the biological engineering of valuable compounds from renewable feedstock. The projects developed by Alderys are aimed at the chemical and cosmetic industry sectors as well as nutrition.
Maurizio Volpi, president of Givaudan’s fragrance division, commented: “The acquisition of Alderys aligns with our long-term strategy for Active Beauty and more specifically, their expertise in biotechnology is fully complementary to our Fragrance and Active Beauty businesses. It will allow us to expand our portfolio of natural and bio-sourced products, thanks to their strong research and development in bioengineering platform.
“It will be an additional tool to drive our future development and innovation in the active cosmetic ingredients space and beyond. It will also reinforce Givaudan’s capabilities to support our customers in developing sustainable, performant and safe products.”
Laurent Bourdeau, head of Givaudan’s Active Beauty business, added: “Alderys has a strong track record in designing innovative biological pathways to produce environmentally-friendly raw materials, which is essential to the way we develop our cosmetic ingredients. With specific scientific programmes dedicated to Active Beauty, we are very excited by the capabilities of Alderys to support us in enriching our offer to our customers.”